Resumo

RAUBENHEIMER, EJ. Part III: Metabolic bone disease: Recent developments in the pathogenesis of endocrine-, drug-, genetic-, renal-, HIV-, and malignancy-induced bone disease. SA orthop. j. [online]. 2009, vol.8, n.3, pp.18-23. ISSN 2309-8309.

A thorough understanding of the pathogenesis of bone changes is a prerequisite for the prevention and effective management of skeletal debilitation resulting from metabolic derangements. This article deals with recent developments in the pathogenesis of bone disease as a result of endocrine abnormalities, drugs, genetic and renal diseases, HIV and malignancy.

        · texto em Inglês     · Inglês ( pdf )